A 45-year-old man presented in June 2014 with painless visible haematuria and no other lower urinary tract symptoms. Examination revealed normal external genitalia and a small benign-feeling prostate. Haemoglobin, white cell count, renal function and adjusted calcium were within normal limits. The patient had curative autologous stem cell transplantation for multiple myeloma previously in January 2013. Flexible cysto-urethroscopy revealed a pedunculated, 'polyp-like' lesion arising from the ventral aspect of the mid-urethra (Figure 1) and normal bladder urothelium. Transurethral resection under general anaesthetic was performed. Histology showed a poorly differentiated neoplasm with malignant plasma cell infiltrate of plasmablastic morphology. The cells were strongly positive for CD138 (Figure 2) and negative for CD79a, CAM5.2, p63 and MNF116 (Figure 3) on immunohistochemistry. A provisional diagnosis of myeloma recurrence was made. Further staging investigations revealed a para-spinal and rib lesion. Biopsy of the latter revealed plasma cell myeloma confirming relapse. Chemotherapy was initiated. Discussion Multiple myeloma accounts for 0.8% of all new cancer cases annually. Soft tissue deposits of myeloma are usually confined to the liver, spleen, lymph nodes, nasopharyngeal and para-nasal sinuses. 1-2 Urethral involvement is exceptionally rare (either in isolation (extramedullary plasmacytoma) or with bony involvement (multiple myeloma)). There are only eight published cases of urethral extramedullary plasmacytoma. 3-10 Five of these patients were treated with primary radiotherapy, four of whom remained disease free at follow up (ranging from six months to 12 years), the other relapsing at one year, requiring a urethrectomy. The remaining three had primary surgical excision with or without adjuvant radiotherapy and remained recurrence free at follow up (ranging from six months to 10 years). Up to 50%